Cardio Diagnostics logo
Cardio Diagnostics
CDIO | NASDAQ
Chart Builder DCF Calculator
$1.79
-$0.10 (-5.29%)
At close: Nov 16, 2026, 4:00 PM ET
$1.82
+$0.03 (+1.68%)
After-hours: Nov 16, 2026, 7:30 PM ET

Cardio Diagnostics Company Profile

Company profile explained

Company Profile

Cardio Diagnostics Holdings, Inc. specializes in creating and bringing to market advanced clinical diagnostic tools that leverage epigenetic insights to address cardiovascular disease. Among their key offerings is Epi+Gen CHD, a test designed to assess an individual's three-year risk for developing symptomatic coronary heart disease. This company, headquartered in Chicago, Illinois, was established in 2017.

Key Executives

Name Position
Meeshanthini Dogan Co-Founder, Chief Executive Officer & Director
Elisa Michael Luqman Chief Financial Officer & Principal Accounting Officer
Timur Dogan Chief Technology Officer
Robert A. Philibert Co-Founder, Chief Medical Officer & Director

Latest SEC Filings

Date Type Title
Oct 02, 2026 4 Filing
Oct 02, 2026 4 Filing
Oct 02, 2026 4 Filing
Oct 02, 2026 4 Filing
Sep 18, 2026 8-K Current Report
Sep 08, 2026 DEFA14A Filing
Aug 20, 2026 8-K Current Report
Aug 07, 2026 10-Q Quarterly Report
Aug 07, 2026 DEFA14A Filing
Aug 05, 2026 DEF 14A Filing
View All SEC Filings ➞
Cardio Diagnostics
Cardio Diagnostics logo
Country United States
IPO Date Jan 14, 2022
Industry Biotechnology
Sector Healthcare
Employees 15
CEO Meeshanthini V. Dogan

Contact Details

311 West Superior Street Chicago, Illinois 60654 United States

Stock Details

Ticker Symbol CDIO
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001870144
CUSIP Number 14159C202
ISIN Number US14159C2026
SIC Code 2835

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.